World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
45776
World Ranking
17788
National Ranking
49

Jose C. Nicolau publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jose C. Nicolau sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 540 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jose C. Nicolau D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jose C. Nicolau sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jose C. Nicolau is affiliated with the Universidade de São Paulo in Brazil. Their research is primarily situated within the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine, where they have contributed to 129 publications. Additional subfields of study include Surgery, Endocrinology, Diabetes and Metabolism, Infectious Diseases, and Radiology, Nuclear Medicine and Imaging.

The scientist's work covers several key topics relevant to cardiovascular and metabolic health, including:

  • Antiplatelet Therapy and Cardiovascular Diseases
  • Acute Myocardial Infarction Research
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Cardiac Imaging and Diagnostics

Jose C. Nicolau has an extensive publication record in notable journals and venues. Some of the frequent publication venues are:

  • Journal of the American College of Cardiology
  • Circulation
  • European Heart Journal
  • Arquivos Brasileiros de Cardiologia
  • Zenodo (CERN European Organization for Nuclear Research)

Among the recent papers coauthored or associated with Nicolau are:

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (2020) published in The Lancet
  • Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021), Bristol Research (University of Bristol)
  • Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes (2020) in JAMA
  • Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial (2022), European Heart Journal
  • Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists (2021), JACC Heart Failure

Jose C. Nicolau has collaborated frequently with several researchers, including:

  • Talia Falcão Dalçóquio
  • Rocío Salsoso
  • Felipe Gallego Lima
  • Remo Holanda de Mendonça Furtado
  • Luciano Baracioli

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

    Marc P. Bonaca;Deepak L. Bhatt;Marc Cohen;Philippe Gabriel Steg

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Vorapaxar in the secondary prevention of atherothrombotic events

    David A. Morrow;Eugene Braunwald;Marc P. Bonaca;Sebastian F. Ameriso

  • Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

    Robert O. Bonow;Gerald Maurer;Kerry L. Lee;Thomas A. Holly

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

  • Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

    Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

  • Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

    A. Michael Lincoff;Stephen J. Nicholls;Jeffrey S. Riesmeyer;Philip J. Barter

  • IV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia

    Andrei C. Sposito;Bruno Caramelli;Francisco A. H. Fonseca;Marcelo C. Bertolami

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients

    Paul M. Ridker;James Revkin;Pierre Amarenco;Robert Brunell

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

    Piotr Ponikowski;Bridget-Anne Kirwan;Bridget-Anne Kirwan;Stefan D Anker;Theresa McDonagh;Theresa McDonagh

  • Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure

    Bertram Pitt;Harvey White;Jose Nicolau;Felipe Martinez

  • Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.

    Stefan James;Dominick J. Angiolillo;Jan H. Cornel;David Erlinge

  • Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Results From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

    Claes Held;Nils Åsenblad;Jean Pierre Bassand;Richard C. Becker

  • Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial.

    Christopher B. Granger;Kenneth W. Mahaffey;W. Douglas Weaver;Pierre Theroux

  • International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina

    E Topol;R Califf;F Van De Werf;R Diaz

  • Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes

    Mark C Petrie;Subodh Verma;Kieran F Docherty;Silvio E Inzucchi

Frequent Co-Authors

Shaun G. Goodman
Shaun G. Goodman University of Toronto
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Christopher B. Granger
Christopher B. Granger Duke University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Robert F. Storey
Robert F. Storey University of Sheffield
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
Eugene Braunwald
Eugene Braunwald Harvard Medical School
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Harvey D. White
Harvey D. White Auckland City Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if a traditional medical degree is right for you? There are a variety of flexible, online options to explore.

Consider a pharmacy degree online if you are drawn to medication management, patient care, and pharmaceutical research. Pharmacy programs can open doors to rewarding roles beyond hospitals, including research, retail, or industry settings.

If you like working with data and technology, healthcare informatics degree programs train students to manage and analyze health information, a crucial skill for modern healthcare systems.

For those seeking quick entry into the healthcare field, you might wonder how much is medical billing and coding school. Training can often be completed in under a year, leading to roles in hospitals, clinics, or insurance companies.

Nurses wanting to advance should look into the cheapest fnp programs online. These programs prepare you for high-demand nurse practitioner positions while letting you study flexibly.

Each of these online pathways offers a unique route into healthcare careers, accommodating different interests, budgets, and schedules.

Best Scientists Citing Jose C. Nicolau

Trending Scientists

Recently Published Articles